Varonis price target raised to $33 from $28 at Barclays

Barclays raised the firm’s price target on Varonis (VRNS) to $33 from $28 and keeps an Overweight rating on the shares. The company’s new business sounds like it accelerated in Q1, the analyst tells investors in a research note. Barclays thinks Varonis’ annual recurring revenue “has room to keep marching up.”